 |
|
|
|
On this page:
A meta-analysis comparing early hormonal therapy with hormonal therapy given later to men with locally advanced prostate cancer found a decrease in overall mortality for those who received early hormonal therapy, whether or not the patient had other treatment. Hormonal therapy is currently recommended for men at high risk of recurrence. Hormonal therapy following the diagnosis of prostate cancer. Trends –Between 1998 and 2002 there were no significant changes in the use of hormonal therapy. Download: data (Excel) | image (JPEG) The percentage of men with localized/regional prostate cancer given hormonal therapy was highest for those aged 80 years or older (52 percent) and lowest for men aged 40–49 years and 50–59 years (17 percent). There are no Healthy People 2010 targets for prostate cancer treatment. Currently hormone therapy is recommended only for patients at high risk of recurrence. Zeliadt found that in 1999 African-American men aged 65 years or older were less often given androgen depravation therapy than were White men. Additional Information on Prostate Cancer Treatment
|
||||||||||||||||||||||||||||||
|
Back: Ovarian Cancer Treatment
